A series of new studies led by scientists at The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) describe a potential vaccination strategy to jump-start the selection and evolution of ...
Sep 8, 2016
0
38
A University of Wisconsin-Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell. The cells in question are ...
Apr 28, 2016
0
16
Dartmouth researchers studying rats have discovered that activation of designer neural receptors can suppress cravings in a brain region involved in triggering those cravings.
Nov 11, 2015
0
90
Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the ...
Jul 30, 2015
0
63
AIDS vaccine researchers may be one step closer to outwitting HIV, thanks to designer antibodies and antigens made to order at Duke.
Jul 1, 2015
0
71
Just about all parents would agree—infants undergo a nearly magical transformation from 3 to 6 months. Seemingly overnight, they can smile and laugh, and they squeal with delight when tickled. They babble, have "conversations" ...
Jan 12, 2015
0
63
Scientists at The Scripps Research Institute (TSRI) have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site ...
Sep 25, 2014
0
0
(Medical Xpress)—Psychological studies have a bad reputation for delivering results that researchers never reproduce. Repeatedly, psychologists have been unable to replicate the effects of classic studies. To test the reproducibility ...
In the field of drug design, the protein K-Ras is legendary. It's been on everyone's "target" list for more than 30 years due to its status as the most commonly mutated oncogene in human cancers. Despite this high profile, ...
Nov 20, 2013
0
0
An experimental vaccine to protect against respiratory syncytial virus (RSV), a leading cause of illness and hospitalization among very young children, elicited high levels of RSV-specific antibodies when tested in animals, ...
Oct 31, 2013
0
0
